Sweden
EU reviews immunoglobulin medicines over excess allergic reactions
European regulators are reviewing normal human immunoglobulin medicines after reports of allergic reactions occurring more often than expected with certain batches, including potentially life-threatening reactions.
DS+
Continue with a DS+ subscription
Subscribe to continue reading this story and unlock all DailySweden member content.
- Original reporting and exclusive interviews
- Member-only features and analysis
- An advertising-free premium reading experience
Cancel anytime.
Already a subscriber? Sign in
DailySweden
DailySweden's desk of editors, reporters, researchers and investigative journalists. We bring readers factual, truthful and objective reporting on the issues that matter to them.
Corrections›Message DailySweden on Facebook Messenger.